Active Ingredient(s): Methylene Blue
FDA Approved: * April 8, 2016
Pharm Company: * PROVEPHARM SAS
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Provayblue Overview

Methylene blue, also known as methylthioninium chloride, is a salt used as a medication and dye.[4] As a medication, it is mainly used to treat methemoglobinemia.[4][2] Specifically, it is used to treat methemoglobin levels that are greater than 30% or in which there are symptoms despite oxygen therapy.[2] It has previously been used for cyanide poisoning and urinary tract infections, but this use is no longer recommended. ...

Read more Provayblue Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Provayblue Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Methylene Blue
  • Injection: 1%, 50mg/10ml
  • Solution: 10mg/2ml (5mg/ml), 50mg/10ml (5mg/ml)
  • Tablet: 65mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Provayblue: (2 results)

Sorted by National Drug Code
  • 0517-0125 Provayblue 5 mg/ml Intravenous Injection by American Regent, Inc.
  • 0517-0374 Provayblue 5 mg/ml Intravenous Injection by American Regent

Other drugs which contain Methylene Blue or a similar ingredient: (15 results)